Author:
Barker Roger,Mason Sarah L
Reference8 articles.
1. Advancing pharmacotherapy for treating Huntington's disease: a review of the existing literature;Mason;Expert Opin Pharmacother,2016
2. Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study;Reilmann;Lancet Neurol,2018
3. A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease;Mov Disord,2013
4. Safety and exploratory efficacy at 36 months in Open-HART, an open-label extension study of pridopidine in Huntington's disease;McGarry;J Huntingtons Dis,2017
5. Analysis of the actions of the novel dopamine receptor-directed compounds (S)-OSU6162 and ACR16 at the D2 dopamine receptor;Kara;Br J Pharmacol,2010
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献